FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
In a major regulatory leadership decision, the U.S. Food and Drug Administration (FDA) has appointed Dr. Richard Pazdur, a long-time oncology expert, as the director of its Center for Drug Evaluation and Research (CDER). Pazdur, who has been with the FDA since 1999 and previously led the Oncology Center of Excellence, is known for his regulatory innovation and deep expertise.
His track record includes expediting cancer drug approvals and championing patient-centric regulation. Colleagues and patient advocacy groups have praised his scientific integrity and compassion-driven leadership.
This appointment comes amid a broader shake-up at the FDA, and brings a steady, experienced hand to one of the agency’s most critical divisions — which oversees both prescription and over-the-counter medicines.
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
FDA Tightens the Solvent Side of Natural Color Production
-
Thymol Gel Wins EPA Approval for Beekeepers
-
GM Crop Area Reaches 216 Million Hectares
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
Recommend Reading
-
![U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years]()
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
![China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle]()
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
![Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion]()
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
![关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances]()
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
![South Korea Expands Mandatory GMO Labeling to Highly Processed Foods]()
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
![Acetonitrile: Properties, Uses, and Safety]()
Acetonitrile: Properties, Uses, and Safety
-
![Downstream Urgent Purchases Drive Acrylic Market to Decline]()
Downstream Urgent Purchases Drive Acrylic Market to Decline
-
![Warehouse Receipt Cancellation Fuels Market Sentiment, Driving Lithium Carbonate Prices Higher]()
Warehouse Receipt Cancellation Fuels Market Sentiment, Driving Lithium Carbonate Prices Higher
-
![Styrene-Butadiene Rubber Market Struggles to Find Direction]()
Styrene-Butadiene Rubber Market Struggles to Find Direction
-
![Styrene-Butadiene Rubber Market Shows Slight Upward Trend]()
Styrene-Butadiene Rubber Market Shows Slight Upward Trend
